Celldex Therapeutics, Inc. (CLDX) — EPS (Diluted)
| Fiscal Year | EPS (Diluted) | Change YoY |
|---|---|---|
| 2025 | $-3.90 | -59.2% |
| 2024 | $-2.45 | +16.1% |
| 2023 | $-2.92 | -21.7% |
| 2022 | $-2.40 | -46.3% |
| 2021 | $-1.64 | +18.8% |
| 2020 | $-2.02 | +42.5% |
| 2019 | $-3.51 | — |
| Fiscal Year | EPS (Diluted) | Change YoY |
|---|---|---|
| 2025 | $-3.90 | -59.2% |
| 2024 | $-2.45 | +16.1% |
| 2023 | $-2.92 | -21.7% |
| 2022 | $-2.40 | -46.3% |
| 2021 | $-1.64 | +18.8% |
| 2020 | $-2.02 | +42.5% |
| 2019 | $-3.51 | — |